Terumo Corporation (4543.T) Stock

Healthcare · Medical Devices · Member of Nikkei 225

Terumo Corporation (4543.T) closed at JPY 2,302.50 on 2026-10-15, a change of -5.8 % over the past year, with a market capitalization of JPY 3.45T.

Terumo Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Terumo Corporation key figures

Previous close

JPY 2,302.50 (2026-10-15)

1-year change

-5.8 %

Market cap

JPY 3.45T

Enterprise value

JPY 3.52T

P/E ratio (trailing)

20.52

P/E ratio (forward)

22.94

EPS (trailing)

113.86

EPS (forward)

101.83

PEG ratio

2.18

Price to book

2.07

Revenue growth

19.9 %

Earnings growth

68.3 %

Dividend per share (trailing)

30.00

Short ratio

n/a

Employees

n/a

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Terumo Corporation

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Terumo Corporation and compare it with other stocks.